These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 19525483)

  • 21. Assessing the impact of new cervical cancer screening guidelines.
    Baker E
    MLO Med Lab Obs; 2013 Feb; 45(2):28-9. PubMed ID: 24133862
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence of HPV is high among Indian tribal girls and young women, study finds.
    Travasso C
    BMJ; 2015 May; 350():h2692. PubMed ID: 25985348
    [No Abstract]   [Full Text] [Related]  

  • 23. Discrete-time semi-Markov modeling of human papillomavirus persistence.
    Mitchell CE; Hudgens MG; King CC; Cu-Uvin S; Lo Y; Rompalo A; Sobel J; Smith JS
    Stat Med; 2011 Jul; 30(17):2160-70. PubMed ID: 21538985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational modeling of human papillomavirus with impulsive vaccination.
    Berhe HW; Al-Arydah M
    Nonlinear Dyn; 2021; 103(1):925-946. PubMed ID: 33437129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective cohort study to evaluate immunosuppressive cytokines as predictors of viral persistence and progression to pre-malignant lesion in the cervix in women infected with HR-HPV: study protocol.
    Torres-Poveda K; Bahena-Román M; Delgado-Romero K; Madrid-Marina V
    BMC Infect Dis; 2018 Nov; 18(1):582. PubMed ID: 30453958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic mathematical models: An underused platform for HPV research.
    Ryser MD; Gravitt PE; Myers ER
    Papillomavirus Res; 2017 Jun; 3():46-49. PubMed ID: 28720456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Swedish translation and cross-cultural adaptation of the Functional Assessment of Chronic Illness Therapy - Cervical Dysplasia (FACIT-CD): linguistic validity and reliability of the Swedish version.
    Rask M; Oscarsson M; Ludwig N; Swahnberg K
    BMC Womens Health; 2017 Apr; 17(1):24. PubMed ID: 28372548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.
    Skinner SR; Wheeler CM; Romanowski B; Castellsagué X; Lazcano-Ponce E; Del Rosario-Raymundo MR; Vallejos C; Minkina G; Pereira Da Silva D; McNeil S; Prilepskaya V; Gogotadze I; Money D; Garland SM; Romanenko V; Harper DM; Levin MJ; Chatterjee A; Geeraerts B; Struyf F; Dubin G; Bozonnat MC; Rosillon D; Baril L;
    Int J Cancer; 2016 May; 138(10):2428-38. PubMed ID: 26685704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom.
    Van Effelterre TP; Hogea C; Taylor SM
    Hum Vaccin Immunother; 2016; 12(1):8-19. PubMed ID: 26090944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia.
    Torres-Poveda K; Bahena-Román M; Madrid-González C; Burguete-García AI; Bermúdez-Morales VH; Peralta-Zaragoza O; Madrid-Marina V
    World J Clin Oncol; 2014 Oct; 5(4):753-63. PubMed ID: 25302175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of anal dysplasia in an HIV-infected clinical care cohort: estimates using multi-state Markov modeling.
    Mathews WC; Agmas W; Cachay ER; Cosman BC; Jackson C
    PLoS One; 2014; 9(8):e104116. PubMed ID: 25101757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: Data from the health check-ups of 7,014 Korean women.
    Kim MJ; Kim JJ; Kim S
    Obstet Gynecol Sci; 2013 Mar; 56(2):110-20. PubMed ID: 24327989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.
    Jaisamrarn U; Castellsagué X; Garland SM; Naud P; Palmroth J; Del Rosario-Raymundo MR; Wheeler CM; Salmerón J; Chow SN; Apter D; Teixeira JC; Skinner SR; Hedrick J; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; Bosch FX; de Carvalho NS; Germar MJ; Peters K; Paavonen J; Bozonnat MC; Descamps D; Struyf F; Dubin GO; Rosillon D; Baril L;
    PLoS One; 2013; 8(11):e79260. PubMed ID: 24260180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calibration of complex models through Bayesian evidence synthesis: a demonstration and tutorial.
    Jackson CH; Jit M; Sharples LD; De Angelis D
    Med Decis Making; 2015 Feb; 35(2):148-61. PubMed ID: 23886677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inference of type-specific HPV transmissibility, progression and clearance rates: a mathematical modelling approach.
    Johnson HC; Elfström KM; Edmunds WJ
    PLoS One; 2012; 7(11):e49614. PubMed ID: 23185383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of liquid-based cytology in decreasing the incidence of cervical cancer.
    Gibb RK; Martens MG
    Rev Obstet Gynecol; 2011; 4(Suppl 1):S2-S11. PubMed ID: 21617785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calibrating models in economic evaluation: a comparison of alternative measures of goodness of fit, parameter search strategies and convergence criteria.
    Karnon J; Vanni T
    Pharmacoeconomics; 2011 Jan; 29(1):51-62. PubMed ID: 21142278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calibrating models in economic evaluation: a seven-step approach.
    Vanni T; Karnon J; Madan J; White RG; Edmunds WJ; Foss AM; Legood R
    Pharmacoeconomics; 2011 Jan; 29(1):35-49. PubMed ID: 21142277
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.